Gulf Times - covid-19-vaccine
Moderna sees 20mn doses of Covid-19 vaccine candidate by year end

Moderna sees 20mn doses of Covid-19 vaccine candidate by year end

Moderna Inc said on Friday it was on track to produce 20 million doses of its experimental coronavirus vaccine by the end of the year, while maintaining its goal of readying 500 million to 1 billion doses in 2021.

Russia produces first batch of virus vaccine: ministry

Russia produces first batch of virus vaccine: ministry

Russia said Saturday that it has produced the first batch of its coronavirus vaccine, after President Vladimir Putin announced it had been first in the world to approve a vaccine.

Britain lines up more potential Covid-19 vaccine supplies with J&J, Novavax deals

Britain lines up more potential Covid-19 vaccine supplies with J&J, Novavax deals

Britain will buy potential Covid-19 vaccines from US drugmakers Johnson & Johnson and Novavax Inc, the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on.

Vietnam to buy Russian Covid-19 vaccine

Vietnam to buy Russian Covid-19 vaccine

Vietnam has registered to buy a Russian Covid-19 vaccine, state television reported on Friday, as it fights a new outbreak after going several months with no local cases.

Russia says medics to get anti-Covid shots in two weeks, some Russians wary

Russia says medics to get anti-Covid shots in two weeks, some Russians wary

Russia said on Wednesday the first batch of the world's first Covid-19 vaccine would be rolled out within two weeks and rejected as "groundless" safety concerns aired by some experts over Moscow's rapid approval

German institute says Covid-19 vaccine could be available in autumn

German institute says Covid-19 vaccine could be available in autumn

Germany's leading infectious disease institute said on Wednesday a first vaccine against the coronavirus could be available as early as autumn but warned that it may take longer to control the pandemic.

Scientists ask: Without trial data, how can we trust Russia's Covid vaccine?

Scientists ask: Without trial data, how can we trust Russia's Covid vaccine?

An announcement by Russia on Tuesday that it will approve a Covid-19 vaccine after less than two months of human testing prompted alarm among global health experts, who said that with no full trial data, the vaccine is hard to trust.

EU health commissioner: Vaccine could be available by end of 2020

EU health commissioner: Vaccine could be available by end of 2020

European Union Health Commissioner Stella Kyriakides said a vaccine for Covid-19 could become available by the end of 2020.

India's Wockhardt to make Covid-19 vaccines for UK

India's Wockhardt to make Covid-19 vaccines for UK

Indian drugmaker Wockhardt Ltd will supply millions of doses of multiple Covid-19 vaccines to the United Kingdom, it said on Monday.

Russia preparing mass vaccination against coronavirus for October

Russia preparing mass vaccination against coronavirus for October

Russia is preparing to start a mass vaccination campaign against the novel coronavirus in October, Health Minister Mikhail Murashko said on Saturday, RIA news agency reported.

Russian Covid-19 vaccine approval imminent, source says

Russian Covid-19 vaccine approval imminent, source says

Russia's first potential Covid-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters.

Moderna says Covid-19 vaccine pricing to ensure broad access

Moderna says Covid-19 vaccine pricing to ensure broad access

Moderna Inc plans to price its experimental coronavirus vaccine in a way that ensures broad access, it said on Wednesday, adding that it did not intend to conduct late-stage trials of the vaccine outside the United States.